Inari Medical, Inc., a pioneering commercial-stage medical device company dedicated to advancing the treatment of venous diseases, has successfully raised an impressive $4.9 billion in its latest funding round. This substantial investment underscores the growing recognition of Inari Medical's innovative approach to transforming patient care within the vascular health sector. By designing cutting-edge products that address unmet needs in the treatment of various venous conditions, Inari Medical positions itself at the forefront of a vital healthcare niche. The funding will be strategically allocated to accelerate the development and launch of new technologies aimed at enhancing the quality of life for patients afflicted with these debilitating diseases. Furthermore, this capital will bolster research and development efforts, allowing the company to expand its product portfolio and reach more patients who can benefit from improved therapies. As the demand for effective solutions for venous disease continues to rise, Inari Medical is poised to innovate and lead with its commitment to excellence in medical device manufacturing. The successful fundraising round is a testament to the company’s strong market position and the confidence investors have in its future prospects to deliver life-changing solutions. With this significant influx of capital, Inari Medical is excited to embark on the next phase of its journey towards revolutionizing the treatment paradigm for venous diseases, ultimately ensuring that more patients receive the care they deserve.
Inari Medical Secures $490 Million Funding to Revolutionize Venous Disease Treatments
Get the full Inari Medical company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
mbiomics GmbH
We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life.
$35.3M Series a
today
wet hydration
Wet hydration is your everyday upgrade. Hydration that does more, tastes better, and moves with you. IG & TikTok:@wethydration
$10.0M Unknown
today
Zellify
Zellify is building the Web2App infrastructure for mobile app companies. We help mobile apps monetize outside traditional app stores — without the 30% cut. From onboarding and paywalls to external checkout, entitlement sync, and analytics — Zellify gives you everything you need to scale mobile revenue on your own terms. Whether you're building a finance app, a health tool, or an AI-based learning platform, Zellify helps you keep more, launch faster, and stay in control. Zero setup fees. Zero monthly minimums. Full ownership of your funnel, data, and revenue. We’re proud to support a new wave of mobile-first businesses adapting to the post-App Store era. Learn more: https://web-to-app.zellify.app
$3.7M Seed
today
Windmill
Windmill is the first context graph for your people: a continuous, cited understanding of your workforce so HR can lead strategically, managers can see their teams clearly, and every person's work speaks for itself.
$12.0M Seed
today
Hypervision Surgical
Hypervision Surgical Ltd is a spin-out company formed from King's College London and was founded by a team of clinicians, medical imaging and artificial intelligence (AI) experts. Based on safe light alone, our goal is to equip clinicians with advanced computer-assisted tissue analysis for improved surgical precision and patient safety.
$23.0M Series a
today